The new guidelines encourage patients to reduce or eliminate alcohol consumption entirely, compared with the old guidelines. For people who do want to drink alcohol, the new guidelines recommend that ...

Baxdrostat improved ambulatory 24-hour average systolic blood pressure at 12 weeks compared with placebo in patients with ...

Topline data were announced from a phase 3 trial evaluating baxdrostat in patients with treatment-resistant hypertension.

AZN's baxdrostat hit the main goal in the phase III Bax24 study, showing significant blood pressure reductions in patients ...

Obstructive sleep apnoea (OSA) affects up to 1 billion people worldwide and is defined by repeated upper airway collapse ...

Key messages • Blood pressure-lowering medications lower the chance of death and probably reduce heart attacks and strokes in people with hypertension (high blood pressure) 60 y ...

With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC ...

Positive high-level results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ambulatory 24-hour average systolic ...

AstraZeneca's experimental drug baxdrostat significantly lowered blood pressure over a 24-hour period in a late-stage trial ...

In a new study, fixed-dose combination (FDC) of vildagliptin and dapagliflozin demonstrated substantial efficacy and good ...

Feeling dizzy or faint during pregnancy It could be low blood pressure Read ahead to know from an expert about what’s normal what’s risky and how to manage it safely ...

EPA's approval of Montana DEQ relying on narrative instead of numeric water quality standards for nutrients smacks of ...